Quentin F. Urquhart, Jr. Member 400 Poydras Street, Suite 2700 New Orleans, Louisiana 70130 firstname.lastname@example.org 504.310.2107 504.310.2101 Practice Description
Quentin defends individual and multi-party personal injury and property damage claims. A major focus of his practice is in the products liability area and includes claims involving pharmaceuticals, medical devices, trucks, recreational vehicles, hydraulic components, electrical components, and industrial machinery. In the toxic tort area, Quentin has defended class actions and individual claims involving pesticides, termiticides, solvents, fumigants, agricultural and household products, construction materials, radiation exposures, and asbestos. Quentin also routinely defends claims in the areas of consumer fraud, premises liability, automotive/ trucking, nursing home liability, and industrial accidents. Quentin’s complex litigation and mass tort experience includes multiple roles in a wide variety of matters including: Apple iPhone 3G Marketing MDL: Liaison Counsel; Reglan®: National Coordinating Counsel; Norplant® Contraceptive: Louisiana Trial and Coordinating Counsel; Chinese Manufactured Drywall MDL: Hormone Replacement Therapy: Regional Counsel; Louisiana Trial Counsel; Albuterol Sulfate: National Liaison Counsel (vendors); Rezulin®: Louisiana and National Trial Counsel; Propulsid® MDL: National Trial Team; Cox-II MDL Litigation: National Trial Team; Orthopedic Knee Implants: National Trial Team; HTR- PMI Implants: Louisiana Trial Counsel; Imitrex®: Louisiana Trial Counsel and National Trial Team; Wood Destroying Organisms: National and Regional Counsel; Penile Implants: Louisiana Trial Counsel/National Trial Team; Breast Implants: Louisiana Trial Counsel; Insecticides: Louisiana Trial Counsel; Synthetic Stucco: Louisiana Trial Counsel; Termiticides: Louisiana Trial Counsel. Quentin’s Martindale-Hubbell rating is AV®.* Affiliations, Activities, and Accomplishments
Quentin served as President of the International Association of Defense Counsel (IADC) from 2012-2013. Prior to his election as President, Quentin served on the IADC Board of Directors (2008-2012), was Major CLE Program Chair for the 2009 IADC Mid-Year Meeting, and chaired the IADC Drug, Device & Biotechnology Committee from 2002 to 2004. He also served as a member of the 2005 IADC Trial Academy. He is currently a member of the Board of Directors of the Defense Research Institute (DRI) and the Lawyers for Civil Justice (LCJ). He is also an active member of the American Bar Association (ABA), the Product Liability Advisory Council (PLAC), the Federation of Defense and Corporate Counsel (FDCC), and the Louisiana Association of Defense Counsel (LADC). In 2013, he was appointed by Chancellor Jack Weiss as a member of the Law Center Alumni Board of Trustees for LSU Paul M. Hebert Law Center. Quentin is admitted to practice before the United States Supreme Court, all Louisiana state courts, the United States Court of Appeals for the Fifth Circuit, and the United States District Courts for the Eastern, Middle, and Western Districts of Louisiana. He has also been admitted to practice in numerous courts across the United States on a pro hac basis. *CV, BV, and AV are registered certification marks of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedures, standards, and policies
Quentin received his B.S. (1981) from Trinity University, where he majored in Business Administration and graduated cum laude. He received his J.D. (1984) from Louisiana State University Paul M. Hebert Law Center where he was elected President of his Senior Class. Quentin received an L.L.M., with distinction (2009) in Energy & Environmental Law from Tulane University School of Law.
Quentin has been recognized by many of the leading peer-review publications in the legal profession, including: “The Best Lawyers in America”** in the areas of Insurance Law, Litigation – Environmental, Product Liability Litigation- Defendants, and Mass Tort Litigation/ Class Action - Defendants by Best Lawyers, “Who’s Who of International Product Liability Defense Lawyers” and “The International Who’s Who of Life Sciences Lawyers” by Law Business Research, Ltd., as well as “Super Lawyers” by Thomson Reuters where he is listed as one of the top 50 attorneys in Louisiana. In 2012 he was recognized by Who’s Who Legal to be one of the top ten most highly regarded Product Liability Defence Lawyers in the world. In 2007 he was listed by New Orleans Magazine as one of the Top 50 Lawyers in the New Orleans area, based on his work in the fields of Litigation, Products Liability, and Toxic Torts. Publications
David M. Melancon, Ali A. Spindler, & Quentin F. Urquhart, Jr., Pre-Service Removal Exception to the Forum Defendant Rule Post Amendment of the Federal Jurisdictional Statutes, IADC Trial Techniques and Tactics Committee, March 2012. Quentin F. Urquhart, Jr. & Edward W. Trapolin, Supreme Court Continues Effort To Provide Guidance For Achieving “Error Free” Punitive Damages Awards, IADC Drug, Device and Biotech Committee Newsletter, April 2007. Quentin F. Urquhart, Jr. authored the chapter on "Toxicology" in Challenging Expert Testimony published by Lexis Publishing in 2000.
Quentin F. Urquhart, Jr., Medtronic v. Lohr: Is There A Future For Preemption In Medical Device Cases?, 64 Defense Counsel Journal 45 (1997). Quentin F. Urquhart, Jr., A Primer On Utilizing The Internet In Litigation Practice, 64 Defense Counsel Journal 311 (1997). Quentin F. Urquhart, Jr., Joiner v. General Electric: The Next Chapter In The Supreme Court's Handling Of Expert Testimony, For the Defense, September 1997. Quentin F. Urquhart, Jr., Amount In Controversy And Removal: Current Trends And Strategic Considerations, 62 Defense Counsel Journal 509 (1995). Quentin F. Urquhart, Jr., The Importance Of Documentation In Defending Termite Damage Claims, Pest Control Magazine, June 1993. Quentin F. Urquhart, Jr., Waiver of Defects In Removal Jurisdiction: Another Path Into Federal Court, For The Defense, December 1992. Quentin F. Urquhart, Jr., The Basics of Termite Contractor Liability, Pest Control Technology, February 1992. ** Copyright 2012 by Woodward/White, Inc., of Aiken, S.C
MODELO DE BULA Esta bula é continuamente atualizada, favor proceder a sua leitura antes de utilizar o produto. ALLEGRA® D cloridrato de fexofenadina cloridrato de pseudoefedrina APRESENTAÇÕES Comprimidos revestidos de camada dupla: embalagem com 6 ou 10. USO ORAL. USO ADULTO E PEDIÁTRICO (CRIANÇAS ACIMA DE 12 ANOS). COMPOSIÇÃO ALLEGRA D Cada comprimido revestido
8945d_043-044 6/18/03 11:21 AM Page 43 mac85 Mac 85:1st shift: 1268_tm:8945d: SENDING A SIGNAL THROUGH A GAS For decades scientists have tried to understand how cells work together in tis-sues, as well as in whole organisms. By the 1980s, the identity of many signal-ing molecules, the cellular responses they evoked, and many aspects of intracellu-lar signaling pathways were understood. All t